DAY ONE BIOPHARMACEUTICALS ANTICIPATES TOPLINE RESULTS FROM FIREFLY-2 CLINICAL TRIAL BY MID-2027
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 08 2026
0mins
Source: moomoo
Clinical Trial Announcement: Day One Biopharmaceuticals has announced top-line data from its Firefly-2 clinical trial, which is expected to be released by mid-2027.
Focus on Pediatric Patients: The trial primarily targets pediatric patients, indicating a commitment to addressing unmet medical needs in this demographic.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
